Investor Rights Agreements in the Pharmaceuticals Industry

143 Contracts & Agreements
Browse by Company
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment No. 1 to Ninth Amended and Restated Investor Rights Agreement by and among Lyra Therapeutics, Inc. and Certain Investors
Investor Rights Agreements
Lyra Therapeutics, Inc.
Pharmaceuticals
DE
2023
Investor Rights Agreement among Roivant Sciences Ltd., Pfizer Inc., and Other Investors, Dated November 21, 2022
Investor Rights Agreements
Roivant Sciences Ltd.
Pharmaceuticals
DE
2023
Investor Rights Agreement among Priovant Holdings, Inc., Roivant Sciences Ltd., and Pfizer Inc. dated September 13, 2021
Investor Rights Agreements
Roivant Sciences Ltd.
Pharmaceuticals
DE
2022
Amended and Restated Investors’ Rights Agreement between Ventyx Biosciences, Inc. and Investors (September 9, 2021)
Investor Rights Agreements
Ventyx Biosciences, Inc.
Pharmaceuticals
DE
2021
Amended and Restated Investor Rights Agreement by and among DiCE Molecules Holdings, LLC and Investors (August 20, 2021)
Investor Rights Agreements
DiCE MOLECULES HOLDINGS, LLC
Pharmaceuticals
CA
2021
Investors’ Rights Agreement between Context Therapeutics LLC and Investors (December 22, 2020)
Investor Rights Agreements
Context Therapeutics Inc.
Pharmaceuticals
DE
2021
Anebulo Pharmaceuticals, Inc. Investors’ Rights Agreement with Series A Investors (June 18, 2020)
Investor Rights Agreements
Anebulo Pharmaceuticals, Inc.
Pharmaceuticals
DE
2021
Amendment No. 1 to Amended and Restated Investor’s Rights Agreement by and among Landos Biopharma, Inc. and Certain Investors
Investor Rights Agreements
Landos Biopharma, Inc.
Pharmaceuticals
2023
Investor Rights Agreement between BT DE Investments Inc. and Charlotte’s Web Holdings, Inc. dated November 14, 2022
Investor Rights Agreements
Charlotte's Web Holdings, Inc.
Pharmaceuticals
DE
2022
Investors’ Rights Agreement between Mission Holdings US, Inc. and Investors (May 20, 2022)
Investor Rights Agreements
Medicine Man Technologies, Inc.
Pharmaceuticals
CO
2022
Amended and Restated Investor Rights Agreement among biote Corp., Members, Sponsor, and SPAC Insiders (July 19, 2022)
Investor Rights Agreements
Haymaker Acquisition Corp. III
Pharmaceuticals
DE
2022
Investor Rights Agreement among iAnthus Capital Holdings, Inc., iAnthus Capital Management, LLC, and Certain Investors (June 24, 2022)
Investor Rights Agreements
iANTHUS CAPITAL HOLDINGS, INC.
Pharmaceuticals
DE
2022
Investor Rights Agreement among biote Corp., Members, Sponsor, and SPAC Insiders dated May 26, 2022
Investor Rights Agreements
Haymaker Acquisition Corp. III
Pharmaceuticals
DE
2022
Amendment No. 1 to Investor Rights Agreement between Entasis Therapeutics Holdings Inc. and Innoviva, Inc.
Investor Rights Agreements
Innoviva, Inc.
Pharmaceuticals
DE
2022
Ninth Amended and Restated Investor Rights Agreement by and among Lyra Therapeutics, Inc. and Investors (April 7, 2022)
Investor Rights Agreements
Lyra Therapeutics, Inc.
Pharmaceuticals
DE
2022
Amended and Restated Investors' Rights Agreement by and among AN2 Therapeutics, Inc. and Investors (March 5, 2021)
Investor Rights Agreements
AN2 Therapeutics, Inc.
Pharmaceuticals
DE
2022
Amended and Restated Investors’ Rights Agreement among Eleison Pharmaceuticals Inc., BDI Co., Ltd., and Certain Stockholders
Investor Rights Agreements
Eleison Pharmaceuticals Inc
Pharmaceuticals
DE
2022
Amended and Restated Investors’ Rights Agreement among Eleison Pharmaceuticals Inc., BDI Co., Ltd., and Certain Stockholders
Investor Rights Agreements
Eleison Pharmaceuticals Inc
Pharmaceuticals
DE
2022
Amended and Restated Investors' Rights Agreement by and among CinCor Pharma, Inc. and Investors (September 22, 2021)
Investor Rights Agreements
CinCor Pharma, Inc.
Pharmaceuticals
DE
2021
Second Amended and Restated Investors' Rights Agreement between Amylyx Pharmaceuticals, Inc. and Investors (July 1, 2021)
Investor Rights Agreements
Amylyx Pharmaceuticals, Inc.
Pharmaceuticals
DE
2021
First Amendment to Third Amended and Restated Investors’ Rights Agreement by AEON Biopharma, Inc. and Investors
Investor Rights Agreements
AEON Biopharma, Inc.
Pharmaceuticals
DE
2021
Alphaeon Corporation Third Amended and Restated Investors’ Rights Agreement (April 19, 2017)
Investor Rights Agreements
AEON Biopharma, Inc.
Pharmaceuticals
DE
2021
Amended and Restated Investors’ Rights Agreement between Theseus Pharmaceuticals, Inc. and Investors (January 22, 2021)
Investor Rights Agreements
Theseus Pharmaceuticals, Inc.
Pharmaceuticals
DE
2021
First Amendment to Third Amended and Restated Investors’ Rights Agreement by and among Cognition Therapeutics, Inc. and Certain Stockholders
Investor Rights Agreements
COGNITION THERAPEUTICS INC
Pharmaceuticals
DE
2021
Third Amended and Restated Investors’ Rights Agreement between Cognition Therapeutics, Inc. and Investors (March 20, 2014)
Investor Rights Agreements
COGNITION THERAPEUTICS INC
Pharmaceuticals
DE
2021
Second Amended and Restated Investors' Rights Agreement between Cyteir Therapeutics, Inc. and Investors (February 5, 2021)
Investor Rights Agreements
Cyteir Therapeutics, Inc.
Pharmaceuticals
DE
2021
Voting and Investor Rights Agreement between Alimera Sciences, Inc. and Ocumension Therapeutics (April 14, 2021)
Investor Rights Agreements
ALIMERA SCIENCES INC
Pharmaceuticals
DE
2021
Rain Therapeutics Inc. Amended and Restated Investors' Rights Agreement (September 2, 2020)
Investor Rights Agreements
Rain Therapeutics Inc.
Pharmaceuticals
DE
2021
Fourth Amended and Restated Investors' Rights Agreement among Ikena Oncology, Inc., Investors, and Key Holders
Investor Rights Agreements
Ikena Oncology, Inc.
Pharmaceuticals
DE
2021
Amended and Restated Investors’ Rights Agreement by and among Edgewise Therapeutics, Inc. and Investors (December 3, 2020)
Investor Rights Agreements
Edgewise Therapeutics, Inc.
Pharmaceuticals
DE
2021
Investors’ Rights Agreement among Longboard Pharmaceuticals, Inc., Investors, and Arena Pharmaceuticals, Inc. dated October 27, 2020
Investor Rights Agreements
Longboard Pharmaceuticals, Inc.
Pharmaceuticals
DE
2021
Investors’ Rights Agreement between Terns Pharmaceuticals, Inc. and Investors (December 29, 2020)
Investor Rights Agreements
Terns Pharmaceuticals, Inc.
Pharmaceuticals
DE
2021
Investor's Rights Agreement between Vallon Pharmaceuticals, Inc. and Salmon Pharma GmbH (July 25, 2019)
Investor Rights Agreements
Vallon Pharmaceuticals, Inc.
Pharmaceuticals
NY
2021
Amended and Restated Investor Rights Agreement between Landos Biopharma, Inc. and Investors (August 9, 2019)
Investor Rights Agreements
Landos Biopharma, Inc.
Pharmaceuticals
DE
2021
Voting and Investor Rights Agreement among EyePoint Pharmaceuticals, Ocumension Therapeutics, and EW Healthcare Partners
Investor Rights Agreements
EyePoint Pharmaceuticals, Inc.
Pharmaceuticals
DE
2021
Investors' Rights Agreement among Clever Leaves Holdings Inc. and Certain Shareholders, dated December 18, 2020
Investor Rights Agreements
Clever Leaves Holdings Inc.
Pharmaceuticals
2020
Amended and Restated Investors' Rights Agreement between Tarsus Pharmaceuticals, Inc. and Investors (September 24, 2020)
Investor Rights Agreements
Tarsus Pharmaceuticals, Inc.
Pharmaceuticals
DE
2020
Athira Pharma, Inc. Investors’ Rights Agreement (May 29, 2020)
Investor Rights Agreements
Athira Pharma, Inc.
Pharmaceuticals
DE
2020
Amended and Restated Investors' Rights Agreement between Graybug Vision, Inc. and Investors (July 31, 2019)
Investor Rights Agreements
GRAYBUG VISION, INC.
Pharmaceuticals
DE
2020
Amended and Restated Investors' Rights Agreement between Pliant Therapeutics, Inc. and Investors (December 19, 2019)
Investor Rights Agreements
PLIANT THERAPEUTICS, INC.
Pharmaceuticals
CA
2020